• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Small Dense Low-Density Lipoprotein Cholesterol Predicts Atherosclerotic Cardiovascular Disease in the Copenhagen General Population Study.

作者信息

Balling Mie, Nordestgaard Børge G, Langsted Anne, Varbo Anette, Kamstrup Pia R, Afzal Shoaib

出版信息

J Am Coll Cardiol. 2020 Jun 9;75(22):2873-2875. doi: 10.1016/j.jacc.2020.03.072.

DOI:10.1016/j.jacc.2020.03.072
PMID:32498816
Abstract
摘要

相似文献

1
Small Dense Low-Density Lipoprotein Cholesterol Predicts Atherosclerotic Cardiovascular Disease in the Copenhagen General Population Study.在哥本哈根普通人群研究中，小而密的低密度脂蛋白胆固醇可预测动脉粥样硬化性心血管疾病。
J Am Coll Cardiol. 2020 Jun 9;75(22):2873-2875. doi: 10.1016/j.jacc.2020.03.072.
2
High sdLDL Cholesterol can be Used to Reclassify Individuals with Low Cardiovascular Risk for Early Intervention: Findings from the Chinese Multi-Provincial Cohort Study.高血清 LDL 胆固醇可用于重新分类低心血管风险个体以进行早期干预：来自中国多省份队列研究的结果。
J Atheroscler Thromb. 2020 Jul 1;27(7):695-710. doi: 10.5551/jat.49841. Epub 2019 Oct 30.
3
Metabolic syndrome, low-density lipoprotein cholesterol, and risk of cardiovascular disease: a population-based study.代谢综合征、低密度脂蛋白胆固醇与心血管疾病风险：一项基于人群的研究。
Atherosclerosis. 2006 Dec;189(2):369-74. doi: 10.1016/j.atherosclerosis.2005.12.010. Epub 2006 Jan 23.
4
Apolipoprotein B, non-HDL cholesterol and LDL cholesterol for identifying individuals at increased cardiovascular risk.载脂蛋白 B、非高密度脂蛋白胆固醇和 LDL 胆固醇可用于识别心血管风险增加的个体。
J Intern Med. 2010 Dec;268(6):567-77. doi: 10.1111/j.1365-2796.2010.02277.x.
5
Atherogenic Lipoprotein Determinants of Cardiovascular Disease and Residual Risk Among Individuals With Low Low-Density Lipoprotein Cholesterol.低密度脂蛋白胆固醇水平较低个体中动脉粥样硬化性脂蛋白对心血管疾病及残余风险的影响因素
J Am Heart Assoc. 2017 Jul 21;6(7):e005549. doi: 10.1161/JAHA.117.005549.
6
Non-HDL-cholesterol and apolipoprotein B compared with LDL-cholesterol in atherosclerotic cardiovascular disease risk assessment.非高密度脂蛋白胆固醇和载脂蛋白 B 与 LDL 胆固醇在动脉粥样硬化性心血管疾病风险评估中的比较。
Pathology. 2019 Feb;51(2):148-154. doi: 10.1016/j.pathol.2018.11.006. Epub 2018 Dec 27.
7
HDL subfractions analysis: a new laboratory diagnostic assay for patients with cardiovascular diseases and dyslipoproteinemia.高密度脂蛋白亚组分分析：一种用于心血管疾病和血脂蛋白异常患者的新型实验室诊断检测方法。
Neuro Endocrinol Lett. 2011;32(4):502-9.
8
Treatment and Low-Density Lipoprotein Cholesterol Management in Patients Diagnosed With Clinical Atherosclerotic Cardiovascular Disease in Alberta.艾伯塔省临床动脉粥样硬化性心血管疾病患者的治疗和低密度脂蛋白胆固醇管理。
Can J Cardiol. 2019 Jul;35(7):884-891. doi: 10.1016/j.cjca.2019.04.008.
9
Use of Guideline-Recommended Risk Reduction Strategies Among Patients With Diabetes and Atherosclerotic Cardiovascular Disease.糖尿病和动脉粥样硬化性心血管疾病患者中指南推荐的风险降低策略的应用
Circulation. 2019 Aug 13;140(7):618-620. doi: 10.1161/CIRCULATIONAHA.119.041730. Epub 2019 Jun 7.
10
Effects of weight change on apolipoprotein B-containing emerging atherosclerotic cardiovascular disease (ASCVD) risk factors.体重变化对载脂蛋白 B 所致新兴动脉粥样硬化性心血管疾病（ASCVD）危险因素的影响。
Lipids Health Dis. 2019 Jul 17;18(1):154. doi: 10.1186/s12944-019-1094-4.

引用本文的文献

1
Estimated Small, Dense LDL Cholesterol and Atherosclerotic Cardiovascular Risk in the UK Biobank.英国生物银行中估计的小而密低密度脂蛋白胆固醇与动脉粥样硬化性心血管风险
Arterioscler Thromb Vasc Biol. 2025 Aug 14. doi: 10.1161/ATVBAHA.125.323157.
2
Comparative Efficacy and Safety of Daily Versus Alternate-Day Dosing of Rosuvastatin in Diabetic Dyslipidemia: An Open-Label Clinical Trial.瑞舒伐他汀每日给药与隔日给药治疗糖尿病血脂异常的疗效和安全性比较：一项开放标签临床试验
Cureus. 2025 Jun 6;17(6):e85457. doi: 10.7759/cureus.85457. eCollection 2025 Jun.
3
Clinical significance of small dense low-density lipoprotein cholesterol measurement in type 2 diabetes.
2型糖尿病中小而密低密度脂蛋白胆固醇检测的临床意义
J Diabetes Investig. 2025 Mar;16(3):370-383. doi: 10.1111/jdi.14398. Epub 2025 Jan 7.
4
Real-World safety and effectiveness of evolocumab in primary hypercholesterolemia and mixed dyslipidemia in Saudi Arabia.依洛尤单抗在沙特阿拉伯原发性高胆固醇血症和混合性血脂异常患者中的真实世界安全性和有效性
Saudi Pharm J. 2024 Dec;32(12):102203. doi: 10.1016/j.jsps.2024.102203. Epub 2024 Nov 4.
5
Sex differences in the correlation between lipids related to cardiovascular risk factors and small dense LDL particles in patients with type 2 diabetes.2 型糖尿病患者中与心血管危险因素相关的脂质与小而密 LDL 颗粒之间相关性的性别差异。
Arch Endocrinol Metab. 2024 Oct 1;68:e240069. doi: 10.20945/2359-4292-2024-0069. eCollection 2024.
6
Chios Mastic Gum: A Promising Phytotherapeutic for Cardiometabolic Health.奇亚籽胶：一种有前途的心脏代谢健康植物疗法。
Nutrients. 2024 Sep 2;16(17):2941. doi: 10.3390/nu16172941.
7
Association of cerebrospinal fluid NPY with peripheral ApoA: a moderation effect of BMI.脑脊液神经肽Y与外周载脂蛋白A的关联：体重指数的调节作用。
Nutr Metab (Lond). 2024 Jul 25;21(1):52. doi: 10.1186/s12986-024-00828-6.
8
Relationship between LDL-cholesterol, small and dense LDL particles, and mRNA expression in a cohort of African Americans.非裔美国人队列中低密度脂蛋白胆固醇、小而密低密度脂蛋白颗粒与mRNA表达之间的关系。
Am J Physiol Heart Circ Physiol. 2024 Sep 1;327(3):H690-H700. doi: 10.1152/ajpheart.00332.2024. Epub 2024 Jul 19.
9
Estimated small dense low-density lipoprotein-cholesterol and the risk of kidney and cardiovascular outcomes in diabetic kidney disease.估算的小而密的低密度脂蛋白胆固醇与糖尿病肾病的肾脏和心血管结局风险。
Ren Fail. 2024 Dec;46(2):2369701. doi: 10.1080/0886022X.2024.2369701. Epub 2024 Jul 2.
10
Residual Cardiovascular Risk: Role of Remnants Cholesterol, Monocyte/HDL Ratio and Lipoprotein Ratios on Personalized Cardiovascular Prevention.残余心血管风险：残余胆固醇、单核细胞/高密度脂蛋白比值及脂蛋白比值在个性化心血管预防中的作用
J Pers Med. 2024 Apr 26;14(5):460. doi: 10.3390/jpm14050460.